Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Acute and chronic ataxia

Neurology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull

Synopsis

Distinguish cerebellar ataxia from sensory and vestibular imbalance, identify time-critical acute causes, and investigate subacute or chronic syndromes using a structured, cause-directed neurological pathway.

  • Ataxia is impaired coordination not explained by weakness alone; localise it as cerebellar, sensory, vestibular or mixed before constructing the differential diagnosis.
  • Sudden ataxia, severe gait inability, new headache, diplopia, dysarthria or focal signs is posterior circulation stroke until urgently assessed with brain and vascular imaging.
  • Cerebellar disease produces broad-based gait, truncal instability, dysmetria, intention tremor, dysdiadochokinesia, gaze-evoked nystagmus and scanning or slurred speech.
  • Sensory ataxia accompanies loss of joint position or vibration, pseudoathetosis and a positive Romberg sign; vision improves stance because proprioceptive input is impaired.
  • Vestibular imbalance is dominated by vertigo, oscillopsia and nystagmus, with veering or falling; central eye signs or inability to stand requires urgent stroke expertise.
  • Acute toxic and metabolic causes include alcohol, sedatives, antiseizure toxicity, lithium, hypoglycaemia, electrolyte disturbance and thiamine deficiency; medication and exposure history is essential.
  • Subacute progression raises immune, paraneoplastic, nutritional, infectious and structural disease, whereas long progression suggests genetic or degenerative ataxia but treatable causes still need exclusion.
  • MRI, targeted blood tests, neurophysiology, CSF and genomic testing should follow tempo, localisation and family history; indiscriminate panels create incidental results without replacing neurological assessment.

Key red flags

Abrupt onset, new severe headache, focal weakness, dysarthria, diplopia or inability to stand requires immediate posterior circulation stroke assessment.

Falling consciousness, repeated vomiting or progressive headache with cerebellar signs raises haemorrhage, hydrocephalus or posterior fossa mass effect.

Ataxia with confusion, ocular motor abnormality, malnutrition or alcohol dependence is possible Wernicke encephalopathy and needs immediate parenteral thiamine.

Fever, meningism, immunosuppression or rapidly progressive encephalopathy requires urgent assessment for infection or immune-mediated cerebellitis.

Rapid progression over weeks, weight loss or systemic cancer clues warrants expedited neurological and malignancy evaluation for paraneoplastic or structural disease.

Investigation priorities

01
CT brain and CT angiographyFirst step

Exclude haemorrhage and identify vertebrobasilar occlusion or dissection during sudden-onset ataxia.

Management branches

SUDDENAcute ataxia today

Coordination or gait impairment began suddenly or over a few hours.

  1. Activate emergency neurological assessment, establish last-known-well, check glucose and observations, and identify headache, neck pain, focal signs and anticoagulant exposure.
  2. Arrange urgent non-contrast CT and head-and-neck vascular imaging, with MRI when required, while assessing thrombolysis or thrombectomy eligibility.
  3. Review alcohol, medicines, overdose, infection and electrolyte disturbance in parallel and correct immediately dangerous metabolic abnormalities.
  4. Admit when stroke, persistent severe gait inability, swallowing risk or diagnostic uncertainty remains; do not discharge on a normal early CT alone.

Key medicines

Parenteral thiamineWhen Wernicke encephalopathy is possible, give high-dose intravenous thiamine immediately using the current local alcohol-treatment protocol before or alongside carbohydrate when feasible; never delay emergency glucose for hypoglycaemia.Do not wait for a thiamine result; administer where anaphylaxis can be managed and replace magnesium when deficient because it is required for thiamine-dependent metabolism.
Cause-specific vitamin replacementReplace confirmed vitamin B12, folate or vitamin E deficiency using the relevant NICE, BNF and specialist regimen, with route and duration determined by cause and neurological severity.Take diagnostic blood samples first when safe but never delay emergency thiamine; avoid folate alone until B12 deficiency has been considered and monitor biochemical and clinical response.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG127 suspected neurological conditionsReferral and red-flag assessment of progressive neurological syndromes.
  • National Clinical Guideline for Stroke acute careEmergency posterior circulation recognition and imaging.
  • NICE NG128 stroke recommendationsAcute brain and vascular imaging and reperfusion principles.
  • NHS overview of ataxiaUK clinical overview, causes and multidisciplinary management.
  • NICE NG239 vitamin B12 deficiencyDiagnosis and treatment of B12-related neurological disease.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom